🇺🇸 FDA
Pipeline program

ISIS-GCGRRx - Dose Level 1

ISIS 449884-CS2

Phase 2 small_molecule completed

Quick answer

ISIS-GCGRRx - Dose Level 1 for Type 2 Diabetes Mellitus is a Phase 2 program (small_molecule) at IONIS PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
IONIS PHARMACEUTICALS INC
Indication
Type 2 Diabetes Mellitus
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials